Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF- κB inflammatory signaling pathway
Xyloketal B alleviates cerebral infarction and neurologic deficits in a mouse stroke model by suppressing the ROS/TLR4/NF-κB inflammatory signaling pathway
Acta Pharmacologica Sinica 38,
1236 (September 2017). doi:10.1038/aps.2017.22
Authors: Ni Pan, Liu-yi Lu, Mei Li, Guo-hao Wang, Fang-yun Sun, Hong-shuo Sun, Xue-jun Wen, Jian-ding Cheng, Jian-wen Chen, Ji-yan Pang, Jie Liu, Yong-yuan Guan, Li-yan Zhao, Wen-liang Chen & Guan-lei Wang
Source: Acta Pharmacologica Sinica - Category: Drugs & Pharmacology Authors: Ni Pan Liu-yi Lu Mei Li Guo-hao Wang Fang-yun Sun Hong-shuo Sun Xue-jun Wen Jian-ding Cheng Jian-wen Chen Ji-yan Pang Jie Liu Yong-yuan Guan Li-yan Zhao Wen-liang Chen Guan-lei Wang Tags: xyloketal B stroke ischemic brain injury middle cerebral artery occlusion ROS TLR4 NF- κB Source Type: research